Affiliation:
1. Surgical Outcomes Research Centre Royal Prince Alfred Hospital Camperdown New South Wales Australia
2. Faculty of Medicine & Health Central Clinical School, The University of Sydney Camperdown New South Wales Australia
3. Faculty of Medicine & Health, St George and Sutherland Clinical School University of New South Wales Sydney New South Wales Australia
Abstract
AbstractBackgroundEarly‐onset colorectal cancer (EOCRC) incidence is increasing in Australia. However, no Australian studies have reported on EOCRC patients' surgical management and survival patterns.MethodsA retrospective study of 111 EOCRC patients treated at the Royal Prince Alfred Hospital (RPAH), Sydney, Australia between January 2013 and December 2021 was performed. RPAH is a quaternary referral centre for pelvic exenteration (PE) and cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).ResultsMost patients had left‐sided tumours (76.58%) and stage IV disease at the time of presentation (37.85%). 27.93% of patients underwent either CRS/HIPEC and PE and 72.07% of patients underwent other colorectal resections of which the most common was low anterior resection (19.82%). A stoma was fashioned in 50.54% of patients. Complications occurred in 54.95% of patients of which most were Clavien‐Dindo grade II (47.54%). Absolute 1‐, 3‐ and 5‐year time intervals were 93.69%, 87.39% and 85.48%. Disease‐free and overall survival were poorer in stage IV patients who had PE, followed by CRS/HIPEC then other colorectal resections (P < 0.001 and P = 0.003).ConclusionsStoma formation, PE and CRS/HIPEC and minor postoperative complications were common in our EOCRC cohort. Despite this, the 5‐year absolute survival rate was acceptable. Thus, an aggressive surgical approach in EOCRC patients at a quaternary referral centre may be feasible at the cost of greater postoperative morbidity. This information is imperative in the surgical consent and preoperative counselling of EOCRC patients and highlights the need for further research to assess the postoperative functional outcomes and quality of life of EOCRC patients.